Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
Abstract Background Efflux transporters like MDR1 and MRP2 may modulate the pharmacokinetics of about 50 % of all drugs. It is currently unknown how much of the variation in the activities of important drug membrane transporters like MDR1 or MRP2 is determined by genetic or by environmental factors....
Main Authors: | Johannes Matthaei, Mladen V. Tzvetkov, Valerie Gal, Cordula Sachse-Seeboth, Daniel Sehrt, Jakob B. Hjelmborg, Ute Hofmann, Matthias Schwab, Reinhold Kerb, Jürgen Brockmöller |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | Genome Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13073-016-0372-2 |
Similar Items
-
Grundlegende Untersuchungen zur erblichen Variation der Aktivitäten der Efflux-Transportproteine MDR1 und MRP2: Eine Zwillingsstudie mit Talinolol als In-vivo-Testsubstanz
by: Gal, Valerie Eva
Published: (2016) -
Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation, in vitro and in vivo Assessment
by: Mohsin Kazi, et al.
Published: (2019-05-01) -
Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure
by: Consolación Melguizo, et al.
Published: (2012-12-01) -
MCF-7 İnsan Meme Kanseri Hücre Soyunda Doksorubisin Öncesi ve Sonrası GST İzozimlerinin, İlaç Dirençlilik Proteinlerinin ve Apoptotik Etkisinin Araştırılması
by: Mustafa Türk, et al.
Published: (2020-04-01) -
Adverse Drug Reactions After Administration of Emodepside/Praziquantel (Profender®) in an MDR1-Mutant Australian Shepherd Dog: Case Report
by: Daniela Gaens, et al.
Published: (2019-09-01)